Drug Trial Radar · NCT00959764
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women
Last checked: Nov 20, 2026Latest source record: Nov 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
565
Actual
Start
Jun 2009
Primary completion
Feb 2011
Study completion Feb 2011
Sponsor
- Lead sponsor
- Tarsa Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 17, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effectiveness and tolerability of two medications, calcitonin nasal spray and a tablet containing calcitonin, in postmenopausal women with osteoporosis. Osteoporosis is the term used to describe a large group of diseases, which are characterized by loss of bone density, which makes the bones weaker. Osteoporosis often occurs in postmenopausal women. Calcitonin is a hormone found in the human body. Together with other substances, it regulates the concentration of calcium in the blood and inhibits the natural resorption of bone. Both medications in this study contain salmon calcitonin (sCT), because this form of calcitonin is more active than human calcitonin when used as a medicine. The calcitonin Nasal Spray used in this study is registered and available to doctors in United States for the treatment of osteoporosis. The medication being tested in this study is an oral tablet form of salmon calcitonin.
Conditions
- Osteoporosis, Postmenopausal
Interventions
Oral Calcitonin TabletsDrug
Oral Calcitonin tablets along with matching placebo intranasal spray
Intranasal CalcitoninDrug
Intranasal Calcitonin Spray
Placebo tablets and placebo intranasal sprayDrug
Oral Placebo Tablets/Intranasal placebo spray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Bone Mineral Density (BMD) of Axial Lumbar SpineTime frame: 48 weeks
Locations
20 sites in 6 countries. Site status is shown where the registry gives one.
Rheumatology Associates of N. AL, P.C.
Huntsville, Alabama
Northern California Institute for Bone Health, Inc.
Oakland, California
Desert Medical Advances
Palm Desert, California
Bethesda Health Research Center/Bone Health Center of Bethesda
Bethesda, Maryland
801 N. 30th Street, Suite 6718
Omaha, Nebraska
New Mexico Clinical Research & Osteoporosis
Albuquerque, New Mexico
Bone Mineral Research Center
Mineola, New York
Altoona Center for Clinical Research
Duncansville, Pennsylvania
University of Wisconsin-Geriatrics & Endocrinology/Medical Sciences Center
Madison, Wisconsin
Diagnostic Consultative Centre, "Sveta Anna" EOOD Sofia (Rheumatology Outpatient Office)
Sofia, Sofia, Bulgaria
Synexus Hungary Ltd
Budapest, Hungary
Synexus SCM Sp zoo
Wroclaw, Wroclaw, Poland
Clinical Research Centres SA (Pty) Ltd
Gauteng, Pretoria, South Africa
Synexus Thames Valley Clinical Research Centre
Reading, Berkshire, United Kingdom
Synexus Midlands Clinical Research Centre
Edgbaston, Birmingham, United Kingdom
Synexus Wales Clinical Research Centre
Llanishen, Cardiff, United Kingdom
Synexus Lancashire Clinical Research Centre
Chorley, Chorley, United Kingdom
Synexus Scotland Clinical Research Centre
Clydebank, Glasgow, United Kingdom
Synexus Merseyside Clinical Research Centre
Waterloo, Liverpool, United Kingdom
Synexus Manchester Clinical Research Centre
Manchester, Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.